ALEXANDRIA PHARMACEUTICALSALEXANDRIA PHARMACEUTICALSALEXANDRIA PHARMACEUTICALS

ALEXANDRIA PHARMACEUTICALS

No trades
See on Supercharts
Market capitalization
‪1.55 B‬EGP
‪1.49 M‬
Beta (1Y)
0.27

About ALEXANDRIA PHARMACEUTICALS


CEO
Abla Youssef Abdullah
Headquarters
Alexandria
Founded
1991
ISIN
EGS38341C011
FIGI
BBG000H18VB9
Alexandria Pharmaceuticals engages in the manufacture and trade of pharmaceutical products and appliances for human and veterinary use. The firm also involves in the purchase, sale, import, and export of dietary supplements, cosmetics, and raw materials related to its objectives. The company was founded on July 20, 1991 and is headquartered in Alexandria, Egypt.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬
Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


The current price of AXPH is 310.000 EGP — it has increased by 0.00% in the past 24 hours. Watch ALEXANDRIA PHARMACEUTICALS stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on EGX exchange ALEXANDRIA PHARMACEUTICALS stocks are traded under the ticker AXPH.
AXPH stock has risen by 4.60% compared to the previous week, the month change is a 28.59% rise, over the last year ALEXANDRIA PHARMACEUTICALS has showed a 93.36% increase.
AXPH reached its all-time high on Oct 28, 2024 with the price of 300.000 EGP, and its all-time low was 22.504 EGP and was reached on Dec 28, 2004. View more price dynamics on AXPH chart.
See other stocks reaching their highest and lowest prices.
AXPH stock is 0.81% volatile and has beta coefficient of 0.27. Track ALEXANDRIA PHARMACEUTICALS stock price on the chart and check out the list of the most volatile stocks — is ALEXANDRIA PHARMACEUTICALS there?
Today ALEXANDRIA PHARMACEUTICALS has the market capitalization of ‪1.55 B‬, it has increased by 7.07% over the last week.
Yes, you can track ALEXANDRIA PHARMACEUTICALS financials in yearly and quarterly reports right on TradingView.
AXPH net income for the last quarter is ‪54.07 M‬ EGP, while the quarter before that showed ‪78.64 M‬ EGP of net income which accounts for −31.25% change. Track more ALEXANDRIA PHARMACEUTICALS financial stats to get the full picture.
Yes, AXPH dividends are paid annually. The last dividend per share was 13.00 EGP. As of today, Dividend Yield (TTM)% is 4.19%. Tracking ALEXANDRIA PHARMACEUTICALS dividends might help you take more informed decisions.
Like other stocks, AXPH shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade ALEXANDRIA PHARMACEUTICALS stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So ALEXANDRIA PHARMACEUTICALS technincal analysis shows the buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating ALEXANDRIA PHARMACEUTICALS stock shows the strong buy signal. See more of ALEXANDRIA PHARMACEUTICALS technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.